HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic and prognostic value of T-cell receptor gamma alternative reading frame protein (TARP) expression in prostate cancer.

Abstract
T-cell receptor gamma chain alternative reading frame protein (TARP) has recently been proposed as being up-regulated in prostate cancer (PCA). Additionally, TARP has been proposed as a potential therapeutic target for cancer therapy. We analysed the protein expression of TARP in a large well characterised prostate cancer cohort to assess its diagnostic and prognostic value. Methodologically, we constructed a tissue microarray comprising more than 600 PCA cases including matching benign prostate tissue. TARP protein expression was carefully analysed and associated with clinico-pathological parameters, PSA-relapse free survival and expression data of established and proposed diagnostic markers (AMACR, p63, GOLPH2). Our results show that TARP is significantly over-expressed in the vast majority (approximately 85%) of PCA in comparison to non neoplastic prostate tissue. Its expression was associated with conventional markers of unfavourable and more aggressive tumour behaviour. However, a prognostic value of TARP could not be found. The diagnostic value of TARP is limited in comparison to AMACR, p63 or GOLPH2. Since TARP specific immunologic therapy regimen are currently being tested, the high frequency of TARP over-expression in PCA conveys a high potential for a predictive and potentially therapeutic use of this biomarker.
AuthorsFlorian R Fritzsche, Carsten Stephan, Josefine Gerhardt, Michael Lein, Irina Hofmann, Klaus Jung, Manfred Dietel, Glen Kristiansen
JournalHistology and histopathology (Histol Histopathol) Vol. 25 Issue 6 Pg. 733-9 (06 2010) ISSN: 1699-5848 [Electronic] Spain
PMID20376779 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Nuclear Proteins
  • TARP
  • Prostate-Specific Antigen
Topics
  • Adenocarcinoma (diagnosis, metabolism)
  • Adult
  • Aged
  • Biomarkers, Tumor (metabolism)
  • Blotting, Western
  • Cohort Studies
  • Disease-Free Survival
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Nuclear Proteins (metabolism)
  • Prognosis
  • Prostate-Specific Antigen (blood)
  • Prostatic Neoplasms (diagnosis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: